Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China BioPharma Capital Invests in Quantapore, a Sequencing Device Maker

publication date: Sep 27, 2016
China BioPharma Capital led a Series C financing in Quantapore, a Bay Area sequencing device company. The financial details were not disclosed. China BioPharma Capital is a life science venture capital fund, based in Hong Kong, whose $50 million in initial capital came entirely from Chongqing Lummy Pharma. The fund is run by TVM Capital Life, a Munich-Montreal-Hong Kong investment firm, and plans to in-license China rights for drugs and devices from its portfolio companies. More details....

Stock Symbol: (SHZ: 300006)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital